510(k) Report

510(k) · Cleared

Recalled · 2004

Vysis Urovysion Bladder Cancer Recurrence Kit

K011031510(k) TraditionalCleared Aug 3, 2001120-day reviewClass II21 CFR 866.6010Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vysis · MMW System, Test, Tumor Marker, Monitoring, Bladder

Cleared on Aug 3, 2001 after a 120-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 8 later devices descend from it. It has been recalled once.

Decided
Aug 3, 2001
Review
120 days
Class
Class II
Product code
MMW
Recalls
1
Predicates
0

8 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2005: 1 descendant cleared2014: 1 descendant cleared2011: 1 descendant cleared2008: 1 descendant cleared2007: 2 descendants cleared2010: 1 descendant cleared2013: 1 descendant cleared200020052010201520202025
  1. This deviceK011031 Vysis Urovysion Bladder Cancer Recurrence KitVysis · 2001
  2. Descendant · cites it directly · 7 of its ownK050840 Modification to Duet SystemBioview, Ltd. · 2005
  3. Descendant · 2 generations on · 5 of its ownK061602 Duet SystemBioview, Ltd. · 2007
  4. Descendant · 3 generations on · 2 of its ownK101291 Scanview HER2/Neu Fish SystemApplied Spectral Imaging, Ltd. · 2010
  5. Descendant · 2 generations on · 1 of its ownK110345 Scanview SystemApplied Spectral Imaging · 2011
  6. Descendant · 2 generations on · 0 of its ownK130775 Duet SystemBioview, Ltd. · 2014

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2005: 12007: 22008: 12010: 12011: 12013: 12014: 1
2005high 2 (2007) · low 0 (2006)2026

Most influential descendants

Showing 5 of 8 · See all
  • K050840Modification to Duet SystemBioview, Ltd. · 2005 · cites it directly7descendants
  • K061602Duet SystemBioview, Ltd. · 2007 · 2 generations on5descendants
  • K101291Scanview HER2/Neu Fish SystemApplied Spectral Imaging, Ltd. · 2010 · 3 generations on2descendants
  • K110345Scanview SystemApplied Spectral Imaging · 2011 · 2 generations on1descendant
  • K130775Duet SystemBioview, Ltd. · 2014 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K011031Vysis Urovysion Bladder Cancer Recurrence KitVysis2001—
+1K050840Modification to Duet SystemBioview, Ltd.2005—
+2K061602Duet SystemBioview, Ltd.2007—
+3K101291Scanview HER2/Neu Fish SystemApplied Spectral Imaging, Ltd.2010—
+2K110345Scanview SystemApplied Spectral Imaging2011—
+2K130775Duet SystemBioview, Ltd.2014—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200720
200810
201010
201110
201310
201410
FIG. 1 — Lineage of K011031, 2001–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MMW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MMW device

  1. #1 K203245 Bladder EpiCheck DNA extraction kit…score 5.3 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (8)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K050840Modification to Duet SystemBioview, Ltd.20057

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 19, 2004Not classifiedZ-0640-04OtherSome of the control slides did not have adequate cells deposited upon their surface.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K050840 (Bioview, Ltd., 2005) has gone furthest, with 7 descendants of its own.

How does its category compare?

All MMW devices

MMW System, Test, Tumor Marker, Monitoring, Bladder: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MMW

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MMW

Too few MMW 510(k)s in any year since 2007 to give a median.

Recalls per year · MMW

No recall names MMW since 2007.

Adverse event reports per year · MMW

1in 2013

2010: 12011: 12012: 32013: 1
2007high 3 (2012) · low 0 (2007)2025

MAUDE reports naming product code MMW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—01
20110—01
20120—03
20130—01
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20231—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “K011031: Vysis Urovysion Bladder Cancer Recurrence Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K011031

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026